Core Viewpoint - Catheter Precision, Inc. has successfully completed the acquisition of PeriKard, LLC, which is expected to enhance its offerings in the ventricular therapeutic market [1][2]. Company Overview - Catheter Precision is a U.S.-based innovative medical device company focused on developing solutions for cardiac arrhythmias, particularly in electrophysiology procedures [3]. Acquisition Details - The acquisition of PeriKard was an all-stock transaction that closed within the anticipated timeline, and the technology acquired is expected to complement Catheter Precision's focus on the ventricular therapeutic market [2]. Market Expectations - The company anticipates continued growth in the ventricular therapeutic market segment, supported by the integration of PeriKard's technology [2].
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC